Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gan & Lee Insulin Glargine vs Lantus in Type 1 Diabetes
NCT03371082Phase 3Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Oct 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of fluralaner in type 1 diabetes mellitus (T1D), sponsored by Gan & Lee Pharmaceuticals. Started Oct 2017; status: completed.
02
Drugs
fluralaner
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03371082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371082.